Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription 13.05.2024 4 Am Heart J 4 Am J Cardiol 1 Am J Med 1 Angiology 2 Cardiovasc Res 3 Circ Cardiovasc Interv 1 Circ Res 1 Circulation 1 Clin Cardiol 3 Eur Heart J 1 Hypertension 8 Int J Cardiol 7 J Am Coll Cardiol 1 J Clin Endocrinol Metab 1 J Mol Cell Cardiol 2 J Nucl Med 1 JAMA 1 Mayo Clin Proc 1 Mol Cell Biochem 2 N Engl J Med 3 PLoS One 2 Prog Cardiovasc Dis 1 Psychosom Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. MOK Y, Lu Y, Ballew SH, Sang Y, et al
   Premorbid physical activity and prognosis after incident myocardial infarction: the Atherosclerosis Risk in Communities Study.
   Am Heart J. 2024 May 7:S0002-8703(24)00120-0. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   
2. KIM Y, Park H, Yoon HJ, Suh J, et al
   Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH): Study Protocol for a Randomized Controlled Non-Inferiority Trial.
   Am Heart J. 2024 May 7:S0002-8703(24)00119-4. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   
3. ZHANG F, Tian M, Wang X, Zhang H, et al
   Rationale and design of a Single-center Randomized Trial to Compare the Graft Patency between the Radial Artery and the No-touch Saphenous Vein in Coronary Artery Bypass Grafting Surgery (GRAFT-CAB Study).
   Am Heart J. 2024 May 4:S0002-8703(24)00117-0. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   
4. NICHOLLS SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, et al
   Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in Participants With or at High Risk for Atherosclerotic Cardiovascular Disease: Rationale and Designs of BROADWAY and BROOKLYN.
   Am Heart J. 2024 May 3:S0002-8703(24)00116-9. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

5. ANDERSON JL
   Longer-Duration Dual Antiplatelet Therapy in Medically-Treated Myocardial Infarction: What is the Strength of the Evidence?
   Am J Cardiol. 2024 Apr 20:S0002-9149(24)00275.
   PubMed        
   
   
6. AZZALINI L, Lombardi WL
   Chronic Total Occlusion Percutaneous Coronary Intervention: Mindset, Culture, and Continuous Improvement.
   Am J Cardiol. 2024 May 3:S0002-9149(24)00326.
   PubMed         Abstract available
   
   
7. INADA Y, Suematsu Y, Matsuda T, Yano Y, et al
   Effect of Left Ventricular Diastolic Dysfunction on the Cardiopulmonary Exercise Test in Patients with Cardiovascular Disease.
   Am J Cardiol. 2024 May 2:S0002-9149(24)00336.
   PubMed         Abstract available
   
   
8. ASCANDAR N, Hadaya J, Cho NY, Ali K, et al
   Clinical Outcomes and Resource Utilization in Patients with Peripheral Arterial Disease Hospitalized for Acute Coronary Syndrome.
   Am J Cardiol. 2024 May 1:S0002-9149(24)00331.
   PubMed         Abstract available
   
   

   
   Am J Med

9. SMATI H, Sellke FW, Bourque JM, Qadeer YK, et al
   Coronary Microvascular Dysfunction: A Guide for Clinicians.
   Am J Med. 2024 May 7:S0002-9343(24)00282-1. doi: 10.1016/j.amjmed.2024.
   PubMed         Abstract available
   
   

   
   Angiology

10. LU N, Chi Y, Liu M
    Relationship Between Coronary Artery Revascularization and Postoperative Delirium: Progress and Perspectives.
    Angiology. 2024 May 7:33197241252467. doi: 10.1177/00033197241252467.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

11. SUGIYAMA T, Jang IK
    Is cutting-edge imaging technology superior to conventional angiography in improving outcomes of coronary artery stenting?
    Cardiovasc Res. 2024;120:e17-e19.
    PubMed        
    
    
12. DE WIT S, Geerlings L, Shi C, Dronkers J, et al
    Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
    Cardiovasc Res. 2024 Feb 24:cvae038. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

13. BHARADWAJ AS, Abu-Much A, Maini AS, Zhou Z, et al
    Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
    Circ Cardiovasc Interv. 2024 May 6:e013503.
    PubMed         Abstract available
    
    
14. ANG DTY, Carrick D, Kamdar A, Sykes R, et al
    Intracoronary Adenosine-Derived Coronary Flow Reserve and Index of Microvascular Resistance.
    Circ Cardiovasc Interv. 2024 May 8:e013667.
    PubMed        
    
    
15. NISHI T, Murai T, Waseda K, Hirohata A, et al
    Prognostic Value of Microvascular Resistance Reserve Measured Immediately After PCI in Stable Coronary Artery Disease.
    Circ Cardiovasc Interv. 2024 May 10:e013728.
    PubMed         Abstract available
    
    

    
    Circ Res

16. MENDOZA A, Patel P, Robichaux D, Ramirez D, et al
    Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury.
    Circ Res. 2024;134:1292-1305.
    PubMed         Abstract available
    
    

    
    Circulation

17. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
    Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
    Circulation. 2024;149:1536-1539.
    PubMed        
    
    

    
    Clin Cardiol

18. SHAH BUD, Raj R, Kaur P, Karim A, et al
    Association of transportation noise with cardiovascular diseases.
    Clin Cardiol. 2024;47:e24275.
    PubMed         Abstract available
    
    

    
    Eur Heart J

19. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
    Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
    Eur Heart J. 2024;45:1540-1549.
    PubMed         Abstract available
    
    
20. WU VC, Yeh JK, Chen SW, Wu CL, et al
    Syphilis and cardiovascular risk: a Taiwanese registry.
    Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
    PubMed         Abstract available
    
    
21. HEUSCH G, Kleinbongard P
    Cardioprotection research has left its comfort zone.
    Eur Heart J. 2024;45:1568-1570.
    PubMed        
    
    

    
    Hypertension

22. VRSALOVIC M, Heimark S, Soraas CL, Mehlum MH, et al
    Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial.
    Hypertension. 2024 May 8. doi: 10.1161/HYPERTENSIONAHA.124.22832.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

23. LEE YJ, Park G, Lee SG, Cho YK, et al
    Predictive value of plaque characteristics for identification of lesions causing ischemia.
    Int J Cardiol. 2024;406:132097.
    PubMed         Abstract available
    
    
24. AKSIT E, Kucuk U, Kirilmaz B
    The increasing importance of lipid lowering therapies as a part of the 'first medical contact' in patients with acute coronary syndrome.
    Int J Cardiol. 2024;406:132095.
    PubMed        
    
    
25. GASECKA A, Blazejowska E, Pluta K, Gajewska M, et al
    Ticagrelor downregulates the expression of proatherogenic and proinflammatory miR125-b compared to clopidogrel: A randomized, controlled trial.
    Int J Cardiol. 2024;406:132073.
    PubMed         Abstract available
    
    
26. MOMMERSTEEG PMC, Lodder P, Aarnoudse W, Magro M, et al
    Psychosocial distress and health status as risk factors for ten-year major adverse cardiac events and mortality in patients with non-obstructive coronary artery disease.
    Int J Cardiol. 2024;406:132062.
    PubMed         Abstract available
    
    
27. TILLMANNS J, Weiglein JM, Neuser J, Fraccarollo D, et al
    Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation.
    Int J Cardiol. 2024;406:132044.
    PubMed         Abstract available
    
    
28. REN Y, Chen L, Liu J, Wu Y, et al
    Correlation of epicardial adipose tissue and inflammatory indices in patients with STEMI and implications for atrial arrhythmias.
    Int J Cardiol. 2024;406:132016.
    PubMed         Abstract available
    
    
29. CHADHA RM
    CT coronary angiography: Is it the new standard in coronary assessment for liver transplant candidates?
    Int J Cardiol. 2024;406:131999.
    PubMed        
    
    
30. YAZDANPANAH M, Yazdanpanah N, Chardoli M, Dehghan A, et al
    Role of interleukin 6 signaling pathway in the anti-inflammatory effects of statins on coronary artery disease: Evidence from Mendelian randomization analysis.
    Int J Cardiol. 2024;406:131964.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

31. GUSEH JS 2ND, Januzzi JL Jr
    The Hidden Cardiovascular Crisis Among Former NFL Athletes: After the HUDDLE.
    J Am Coll Cardiol. 2024;83:1838-1840.
    PubMed        
    
    
32. HOLT A, Strange JE, Rasmussen PV, Nouhravesh N, et al
    Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.
    J Am Coll Cardiol. 2024;83:1870-1882.
    PubMed         Abstract available
    
    
33. APPLE FS
    Early Safe Rule Out Using High-Sensitivity Cardiac Troponin: The Role of Sex.
    J Am Coll Cardiol. 2024;83:1867-1869.
    PubMed        
    
    
34. CUBEDDU RJ, Lorusso R, Ronco D, Matteucci M, et al
    Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5.
    J Am Coll Cardiol. 2024;83:1886-1901.
    PubMed         Abstract available
    
    
35. LORUSSO R, Cubeddu RJ, Matteucci M, Ronco D, et al
    Ventricular Pseudoaneurysm and Free Wall Rupture After Acute Myocardial Infarction: JACC Focus Seminar 4/5.
    J Am Coll Cardiol. 2024;83:1902-1916.
    PubMed         Abstract available
    
    
36. LORUSSO R, Matteucci M, Lerakis S, Ronco D, et al
    Postmyocardial Infarction Ventricular Aneurysm: JACC Focus Seminar 5/5.
    J Am Coll Cardiol. 2024;83:1917-1935.
    PubMed         Abstract available
    
    
37. ALEXANDER GC, Moore TJ, Brass EP
    Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
    J Am Coll Cardiol. 2024;83:1883-1885.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

38. FARR JN
    Cardiovascular Safety and Romosozumab - The Plot Thickens.
    J Clin Endocrinol Metab. 2024 May 8:dgae313. doi: 10.1210.
    PubMed        
    
    

    
    J Mol Cell Cardiol

39. MA X, Zhao J, Feng Y
    Epicardial SMARCA4 deletion exacerbates cardiac injury in myocardial infarction and is related to the inhibition of epicardial epithelial-mesenchymal transition.
    J Mol Cell Cardiol. 2024;191:76-87.
    PubMed         Abstract available
    
    

    
    J Nucl Med

40. HOEK R, van Diemen PA, Raijmakers PG, Driessen RS, et al
    Determining Hemodynamically Significant Coronary Artery Disease: Patient-Specific Cutoffs in Quantitative Myocardial Blood Flow Using [(15)O]H(2)O PET Imaging.
    J Nucl Med. 2024 May 9:jnumed.123.267195. doi: 10.2967/jnumed.123.267195.
    PubMed         Abstract available
    
    
41. DIETZ M, Kamani CH, Bousige C, Dunet V, et al
    Natural History of Myocardial alpha(v)beta(3) Integrin Expression After Acute Myocardial Infarction: Correlation with Changes in Myocardial Blood Flow.
    J Nucl Med. 2024 May 9:jnumed.124.267514. doi: 10.2967/jnumed.124.267514.
    PubMed         Abstract available
    
    

    
    JAMA

42. AGGARWAL R, Ostrominski JW, Vaduganathan M
    Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020.
    JAMA. 2024 May 8:e246892. doi: 10.1001/jama.2024.6892.
    PubMed        
    
    

    
    Mayo Clin Proc

43. UENO K, Kaneko H, Suzuki Y, Okada A, et al
    Change in Body Mass Index and Cardiovascular Outcomes in Patients With Cancer.
    Mayo Clin Proc. 2024 May 4:S0025-6196(24)00087.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

44. ZHOU L, Zhu X, Lei S, Wang Y, et al
    The role of the ER stress sensor IRE1 in cardiovascular diseases.
    Mol Cell Biochem. 2024 May 8. doi: 10.1007/s11010-024-05014.
    PubMed         Abstract available
    
    

    
    N Engl J Med

45. GOYAL M, Bosshart SL, Ospel JM
    Tenecteplase for Stroke at 4.5 to 24 Hours.
    N Engl J Med. 2024;390:1729.
    PubMed        
    
    
46. ALBERS GW, Purdon B, Campbell BCV
    Tenecteplase for Stroke at 4.5 to 24 Hours. Reply.
    N Engl J Med. 2024;390:1729.
    PubMed        
    
    

    
    PLoS One

47. BOLGEO T, Di Matteo R, Simonelli N, Dal Molin A, et al
    Psychometric testing of the caregiver contribution to self-care of coronary heart disease inventory.
    PLoS One. 2024;19:e0302891.
    PubMed         Abstract available
    
    
48. FISTER M, Mikuz U, Ziberna K, Franco D, et al
    Early unfractionated heparin treatment in patients with STEMI - trial design and rationale.
    PLoS One. 2024;19:e0303376.
    PubMed         Abstract available
    
    
49. SASSO EH, Mabey B, Flake DD 2nd, Hitraya E, et al
    External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis.
    PLoS One. 2024;19:e0296459.
    PubMed         Abstract available
    
    

    
    Prog Cardiovasc Dis

50. SATISH P, Avenatti E, Patel J, Agarwala A, et al
    Understanding the spectrum of cardiovascular risk in women - A primer for prevention.
    Prog Cardiovasc Dis. 2024 May 4:S0033-0620(24)00070.
    PubMed         Abstract available
    
    
51. GAMI A, Bisht S, Satish P, Blaha MJ, et al
    The utility of coronary artery calcium scoring to enhance cardiovascular risk assessment for South Asian adults.
    Prog Cardiovasc Dis. 2024 May 7:S0033-0620(24)00069.
    PubMed         Abstract available
    
    

    
    Psychosom Med

52. CORNELIUS T, Edmondson D, Abdalla M, Scott A, et al
    Prospective Bidirectional Relationship Between Sleep Duration and Posttraumatic Stress Disorder Symptoms After Suspected Acute Coronary Syndrome.
    Psychosom Med. 2024;86:283-288.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.